Document is current

Any future updates will be listed below

Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer

Crossref DOI link: https://doi.org/10.1007/s10549-017-4138-3

Published Online: 2017-02-08

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark